Background Gray matter (GM) pathology is closely associated with physical and cognitive
impairment in persons with multiple sclerosis (PwMS). Similarly, serum neurofilament light …

Despite that the availability of new therapeutic options has expanded the multiple sclerosis (MS)
disease-modifying therapy arsenal, interferon β (IFN-β) remains an important therapy …

The prevalence of multiple sclerosis (MS) and the age of affected patients are increasing
owing to increased longevity of the general population and the availability of effective disease-…

Multiple sclerosis (MS) is a disease of the central nervous system characterized by
inflammation, demyelination, and neuronal damage. Environmental and genetic factors are …

Background Increasingly favorable mortality prognosis in multiple sclerosis (MS) raises
questions regarding MS-specific cognitive aging and the presence of comorbidities such as …

Background: A limited number of studies investigated associations between serum neurofilament
light chain (sNfL) and cognition in persons with multiple sclerosis (PwMS). Objective: …

Background Evidence regarding the role, if any, of dietary and lifestyle factors in the
pathogenesis of multiple sclerosis (MS) is poorly understood. Objective To assess the effect of …

Introduction: Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and
neurodegenerative disease of the central nervous system. Over the last two decades, more favorable …

Background: Multiple sclerosis (MS) is a chronic neuroinflammatory and neurodegenerative
disease that is associated with multiple environmental factors. Among suspected …

Introduction: Brain atrophy measurement in multiple sclerosis (MS) has become an important
outcome for determining patients at risk for developing physical and cognitive disability. …